Heart toxicity from breast cancer radiotherapy
Authors:
- Marc D. PirothMPMarc D. Piroth
- René BaumannRBRené Baumann
- Wilfried BudachWBWilfried Budach
- Jürgen DunstJDJürgen Dunst
- Petra FeyerPFPetra Feyer
- Rainer FietkauRFRainer Fietkau
- Wulf HaaseWHWulf Haase
- Wolfgang HarmsWHWolfgang Harms
- Thomas HehrTHThomas Hehr
- David KrugDKDavid Krug
- Arnd RöserARArnd Röser
- Felix SedlmayerFSFelix Sedlmayer
Open Access
- 11 October 2018
- journal article
- review article
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 195 (1) , 1-12
Abstract
Background: Late cardiac toxicities caused by (particularly left-sided) breast radiotherapy (RT) are now recognized as rare but relevant sequelae, which has prompted research on risk structure identification and definition of threshold doses to heart subvolumes. The aim of the present review was to critically discuss the clinical evidence on late cardiac reactions based on dose-dependent outcome reports for mean heart doses as well as doses to cardiac substructures. Methods: A literature review was performed to examine clinical evidence on radiation-induced heart toxicities. Mean heart doses and doses to cardiac substructures were focused upon based on dose-dependent outcome reports. Furthermore, an overview of radiation techniques for heart protection is given and non-radiotherapeutic aspects of cardiotoxicity in the multimodal setting of breast cancer treatment are discussed. Results: Based on available findings, the DEGRO breast cancer expert panel recommends the following constraints: mean heart dose meanLV (mean dose left ventricle) < 3 Gy; V5LV (volume of LV receiving ≥5 Gy) < 17%; V23LV (volume of LV receiving ≥23 Gy) < 5%; DmeanLAD (mean dose left descending artery) < 10 Gy; V30LAD (volume of LAD receiving ≥30 Gy) < 2%; V40LAD (volume of LAD receiving ≥40 Gy) < 1%. Conclusion: In addition to mean heart dose, breast cancer RT treatment planning should also include constraints for cardiac subvolumes such as LV and LAD. The given constraints serve as a clinicians’ aid for ensuring adequate heart protection. The individual decision between sufficient protection of cardiac structures versus optimal target volume coverage remains in the physician’s hand. The risk of breast cancer-specific mortality and a patient’s cardiac risk factors must be individually weighed up against the risk of radiation-induced cardiotoxicity.Keywords
This publication has 59 references indexed in Scilit:
- Modern Hypofractionation Schedules for Tangential Whole Breast Irradiation Decrease the Fraction Size-corrected Dose to the HeartClinical Oncology, 2013
- The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UKThe Lancet, 2013
- Dosimetric Comparison of Intensity-Modulated Radiotherapy Plans, With or Without Anterior Myocardial Territory and Left Ventricle as Organs at Risk, in Early-Stage Left-Sided Breast Cancer PatientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Long-Term Cardiovascular Mortality After Radiotherapy for Breast CancerJACC, 2011
- Long-Term Results of Hypofractionated Radiation Therapy for Breast CancerNew England Journal of Medicine, 2010
- Potential Effect of Robust and Simple IMRT Approach for Left-Sided Breast Cancer on Cardiac MortalityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast CancerJNCI: Journal of the National Cancer Institute, 2007
- Late Cardiac Mortality and Morbidity in Early-Stage Breast Cancer Patients After Breast-Conservation TreatmentJournal of Clinical Oncology, 2006
- Randomized Clinical Trial of Breast Irradiation Following Lumpectomy and Axillary Dissection for Node-Negative Breast Cancer: an UpdateJNCI: Journal of the National Cancer Institute, 1996
- Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast CancerNew England Journal of Medicine, 1995